Maryland · 2025 Regular Session · Bill
HB 529: Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 529 is a bill introduced in the Maryland House on January 22, 2025. According to its official title, it concerns: Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars. Primary sponsor: Natalie Ziegler (Democratic), Jen Terrasa (Democratic), Mary Lehman (Democratic), Andrea Harrison (Democratic), Deni Taveras (Democratic). Most recent recorded action (February 17, 2025): Withdrawn by Sponsor.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 5
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Natalie Ziegler | Primary sponsor | Democratic | House | 9A |
| Jen Terrasa | Primary sponsor | Democratic | House | 13 |
| Mary Lehman | Primary sponsor | Democratic | House | 21 |
| Andrea Harrison | Primary sponsor | Democratic | House | 24 |
| Deni Taveras | Primary sponsor | Democratic | House | 47B |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Withdrawn by Sponsor
- Hearing canceled
- Hearing 2/13 at 1:00 p.m.
- First Reading Health and Government Operations